Clinical Trial Update: The Metformin Active Surveillance Trial (MAST) Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for the Metformin Active Surveillance Trial (MAST) in prostate cancer is reported with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Prostate Cancer | Phase 3 | Status: UNKNOWN